1Y Annualised Return
▲46.57%
3Y Annualised Return
▼-0.03%
5Y Annualised Return
▲41.58%
Fredun Pharmaceuticals Stock Performance
|
|
|
Fredun Pharmaceuticals Company background
Founded in: 1987
Managing director: Fredun N Medhora
Incorporated in 1987 as a private limited company, Fredun Pharmaceuticals (FPL) was converted into a public limited company in Mar.94. The Company was promoted by Nariman Medhora and Daulat N Medhora. The promoters initially established D N Pharma, a proprietary firm, for the manufacture and export of pharmaceutical formulations. Since 1993, D N Pharmas operations were phased out in order to switch over the business to FPL. The Company is well diversified in the business ranging from Formulations to Diagnostics to Consultancy. The Company has an unique range of products, from niche formulations , antidiabetics to the latest antiretroviral and anti Hypertensive products. It supplies finished formulations to over 42 Countries globally. It is associated with many Governments of different countries which have also realised the need for robust and consistent healthcare systems.The Company was set up with the objective of providing facilities for manufacturing and marketing of various pharmaceutical formulations like tablets, capsules, drysyrups and ointments. It then set up a formulation unit at Palghar (Thane District), Maharashtra, which commenced commercial production in Aug.94. FPL had been carrying out manufacturing operations on loan licence for reputed pharmaceutical companies like Cipla. It also manufactured for some merchant exporters, including Merind.In Apr.96, the company came out with a public issue to register its products in the overseas market for exports to partfinance the expansion of its business activities and to repay one of the term loans and unsecured loans to reduce the interest burden. Company is very much optimistic of revival of companys turnover by having excellent export order in hand. Company also in process of registering various drugs with different countires such as Nepal, Tanzaniya, Uganda Sri Lanka.In 2013, Company launched 36 new products and filed 60 new products for registration. It launched a herbal dietary supplement in Africa. During 2015, three new granulation departments were introduced to the existing two departments. It launched 19 new products under the Cosmeceuticals OEM Division in 2023. It introduced 14 new products in the pet pharmaceuticals line, with another 36 in the works. It launched 16 products into the Pet Treat and Nutritional Supplement category.
As of 5 Sep, 2025, Fredun Pharmaceuticals share price is ₹1294.9. The stock opened at ₹1304.4 and had closed at ₹1278.8 the previous day. During today’s trading session, Fredun Pharmaceuticals share price moved between ₹1,260.10 and ₹1,325.00, with an average price for the day of ₹1292.55. Over the last 52 weeks, the stock has recorded a low of ₹635.00 and a high of ₹1,329.00. In terms of performance, Fredun Pharmaceuticals share price has increased by 94.2% over the past six months and has increased by 46.57% over the last year.
Fredun Pharmaceuticals SIP Return Calculator
Over the past
1 year
3 years
5 years
Total Investment of ₹65,00,000
Would have become ₹82,84,138 (+27.45%)
Daily SIP of ₹25,000 would have become ₹82,84,138 in 1 year with a gain of ₹17,84,138 (+27.45%)
Fredun Pharmaceuticals Fundamental
Market Cap (in crs)
603.83
Face Value
10
Turnover (in lacs)
113.93
Key Metrics
Qtr Change %
Near 52W High of ₹1329.00
77.5
Dividend yield 1yr %
Low in industry
0.1
Fredun Pharmaceuticals Technical Analysis
Moving Averages Analysis
Moving Averages Analysis
1294.9
Current Price
5Day EMA
1,248.70
10Day EMA
1,209.20
12Day EMA
1,196.20
20Day EMA
1,150.80
26Day EMA
1,121.60
50Day EMA
1,031.50
100Day EMA
926.10
200Day EMA
850.10
5Day SMA
1,238.20
10Day SMA
1,217.30
20Day SMA
1,137.90
30Day SMA
1,089.40
50Day SMA
1,001.00
100Day SMA
866.50
150Day SMA
807.90
200Day SMA
786.10
Delivery & Volume
| Period | Combined Delivery Volume | NSE+BSE Traded Volume |
|---|---|---|
Day Rs | 8798 Rs | 8798 Rs |
Week Rs | 13914 Rs | 13914 Rs |
Month Rs | 17179 Rs | 21183 Rs |
Resistance & Support
1,293.33
Pivot
Resistance
First Resistance
1,326.57
Second Resistance
1,358.23
Third Resistance
1,391.47
Support
First Support
1,261.67
Second support
1,228.43
Third Support
1,196.77
Relative Strength Index
73.03
Money Flow Index
76.82
MACD
74.53
MACD Signal
65.57
Average True Range
66.62
Average Directional Index
54.38
Rate of Change (21)
19.99
Rate of Change (125)
94.20
Fredun Pharmaceuticals Peer comparison
| Index Name | Market Price | Market Cap | 52W Low | 52W High | Prev. Close | 1W Return | 1M Return | 6M Return | 1Y Return | 3Y Return | Dividend Yield | PE Ratio | Industry PE | PB Ratio |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
369.90 | 628.26 | 293.53 | 500 | 359.40 | 9.02% | -15.00% | 21.66% | 12.43% | 128.88% | 0.00% | 19.81 | 40.57 | 2.09 | |
459.35 | 619.96 | 270.25 | 567.8 | 463.80 | 0.75% | -9.76% | 56.19% | 29.27% | 115.91% | 0.00% | 11.79 | 40.57 | 1.05 | |
459.80 | 558.93 | 250 | 625 | 463.45 | -3.62% | -9.13% | 33.33% | 43.78% | 548.06% | 0.00% | 0.00 | 40.57 | 22.22 | |
163.65 | 518.82 | 126.85 | 216.45 | 165.45 | -0.64% | 12.05% | -6.99% | -11.40% | 247.82% | 0.60% | 15.86 | 45.76 | 4.27 | |
571.20 | 758.65 | 500 | 950 | 591.00 | -2.72% | 3.36% | -16.89% | -34.63% | 152.43% | 0.00% | 34.64 | 40.57 | 5.23 | |
Accent Microcell Ltd. | - | 279.00 | - | - | - | - | - | - | - | - | - | - | - | - |
Fredun Pharmaceuticals Share Price FAQs
How to buy Fredun Pharmaceuticals shares?
You can easily buy Fredun Pharmaceuticals shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.
What is the 52-week high and low of Fredun Pharmaceuticals ?
The 52-week high and low of Fredun Pharmaceuticals share price is ₹1329 and ₹635 as of 5/9/2025.
Please be aware that Fredun Pharmaceuticals stock prices are subject to continuous fluctuations due to various factors.
Open Demat Account